杭氧股份(002430.SZ):擬收購空分資產並投資新建一套80000Nm3/h空分裝置項目
格隆匯2月20日丨杭氧股份(002430.SZ)公佈,為加快氣體產業佈局,杭氧集團股份有限公司將以自有資金出資27,100萬元設立全資子公司——澤州杭氧氣體有限公司(暫定名,最終以當地市場監督管理局核准的名稱為準,以下簡稱“氣體公司”),以氣體公司為主體實施受讓山西晉鋼智造科技實業有限公司(以下簡稱“晉鋼智造”)一套30000Nm3/h和一套50000Nm3/h空分裝置(以下簡稱“空分裝置資產組合”)並投資新建一套80000Nm3/h空分裝置的項目,為晉鋼智造提供工業氣體產品及服務,本項目地點位於山西省晉城市澤州縣巴公鎮,項目供氣期限為20年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.